Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Prives

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2016
Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cellsKathryn E Yoh, Kausik Regunath, Asja Guzman, et al.
Cell Cycle (Georgetown, Tex.)|May 24, 2016
Lysines in the tetramerization domain of p53 selectively modulate G1 arrestRachel Beckerman, Kathryn Yoh, Melissa Mattia-Sansobrino, et al.
Cell Cycle (Georgetown, Tex.)|May 26, 2009
Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 proteinJinwoo Ahn, Masha V Poyurovsky, Nicole Baptiste, et al.
Cancer Research|July 27, 2022
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular CarcinomaSawako Suzuki, Divya Venkatesh, Hiroaki Kanda, et al.
Molecular Cell|March 22, 2015
The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domainOleg Laptenko, Idit Shiff, Will Freed-Pastor, et al.
Genes & Development|March 18, 2018
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramersChen Katz, Ana Maria Low-Calle, Joshua H Choe, et al.
The American Journal of Pathology|March 2, 2011
Distinct expression profiles of p63 variants during urothelial development and bladder cancer progressionOrit Karni-Schmidt, Mireia Castillo-Martin, Tian Huai Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2017
STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell CarcinomaYukihiro Otaka, Susumu Rokudai, Kyoichi Kaira, et al.
Nature|November 5, 2004
Regulation of p53 activity through lysine methylationSergei Chuikov, Julia K Kurash, Jonathan R Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stressSladana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2016
Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cellsKathryn E Yoh, Kausik Regunath, Asja Guzman, et al.
Cell Cycle (Georgetown, Tex.)|May 24, 2016
Lysines in the tetramerization domain of p53 selectively modulate G1 arrestRachel Beckerman, Kathryn Yoh, Melissa Mattia-Sansobrino, et al.
Cell Cycle (Georgetown, Tex.)|May 26, 2009
Dissection of the sequence-specific DNA binding and exonuclease activities reveals a superactive yet apoptotically impaired mutant p53 proteinJinwoo Ahn, Masha V Poyurovsky, Nicole Baptiste, et al.
Cancer Research|July 27, 2022
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular CarcinomaSawako Suzuki, Divya Venkatesh, Hiroaki Kanda, et al.
Molecular Cell|March 22, 2015
The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domainOleg Laptenko, Idit Shiff, Will Freed-Pastor, et al.
Genes & Development|March 18, 2018
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramersChen Katz, Ana Maria Low-Calle, Joshua H Choe, et al.
The American Journal of Pathology|March 2, 2011
Distinct expression profiles of p63 variants during urothelial development and bladder cancer progressionOrit Karni-Schmidt, Mireia Castillo-Martin, Tian Huai Shen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2017
STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell CarcinomaYukihiro Otaka, Susumu Rokudai, Kyoichi Kaira, et al.
Nature|November 5, 2004
Regulation of p53 activity through lysine methylationSergei Chuikov, Julia K Kurash, Jonathan R Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stressSladana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, et al.
Pageof 13